Adrenolipoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenolipoma}} | {{Adrenolipoma}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine screening for adrenolipoma. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for adrenolipoma. | |||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
Revision as of 20:45, 9 September 2015
|
Adrenolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenolipoma screening On the Web |
|
American Roentgen Ray Society Images of Adrenolipoma screening |
|
Risk calculators and risk factors for Adrenolipoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for adrenolipoma.
Screening
There is insufficient evidence to recommend routine screening for adrenolipoma.